268 related articles for article (PubMed ID: 25532007)
41. Improvement of DNA repair in lymphocytes of breast cancer patients treated with Viscum album extract (Iscador).
Kovacs E; Hajto T; Hostanska K
Eur J Cancer; 1991; 27(12):1672-6. PubMed ID: 1782081
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic value of high-resolution micro-endoscopy for the classification of colon polyps.
Tan T; Qu YW; Shu J; Liu ML; Zhang L; Liu HF
World J Gastroenterol; 2016 Feb; 22(5):1869-76. PubMed ID: 26855546
[TBL] [Abstract][Full Text] [Related]
43. Tumour response following high-dose intratumoural application of Viscum album on a patient with adenoid cystic carcinoma.
Werthmann PG; Helling D; Heusser P; Kienle GS
BMJ Case Rep; 2014 Jul; 2014():. PubMed ID: 25082867
[TBL] [Abstract][Full Text] [Related]
44. Safety and efficacy of the long-term adjuvant treatment of primary intermediate- to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract. Results from a multicenter, comparative, epidemiological cohort study in Germany and Switzerland.
Augustin M; Bock PR; Hanisch J; Karasmann M; Schneider B
Arzneimittelforschung; 2005; 55(1):38-49. PubMed ID: 15727163
[TBL] [Abstract][Full Text] [Related]
45. Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma.
Mabed M; El-Helw L; Shamaa S
Br J Cancer; 2004 Jan; 90(1):65-9. PubMed ID: 14710208
[TBL] [Abstract][Full Text] [Related]
46. Changes in immunological characteristics of white blood cells after administration of standardized mistletoe extract.
Klopp R; Schmidt W; Niemer W; Werner M; Beuth J
In Vivo; 2001; 15(6):447-57. PubMed ID: 11887328
[TBL] [Abstract][Full Text] [Related]
47. Tolerability of an extract of European mistletoe among immunocompromised and healthy individuals.
Gorter RW; van Wely M; Reif M; Stoss M
Altern Ther Health Med; 1999 Nov; 5(6):37-44, 47-8. PubMed ID: 10550904
[TBL] [Abstract][Full Text] [Related]
48. Safety of higher dosages of Viscum album L. in animals and humans--systematic review of immune changes and safety parameters.
Kienle GS; Grugel R; Kiene H
BMC Complement Altern Med; 2011 Aug; 11():72. PubMed ID: 21871125
[TBL] [Abstract][Full Text] [Related]
49. Subcutaneous infiltrates induced by injection of mistletoe extracts (Iscador).
Gorter RW; van Wely M; Stoss M; Wollina U
Am J Ther; 1998 May; 5(3):181-7. PubMed ID: 10099057
[TBL] [Abstract][Full Text] [Related]
50. Course of mitogen-stimulated T lymphocytes in cancer patients treated with Viscum album extracts.
Büssing A; Stumpf C; Tröger W; Schietzel M
Anticancer Res; 2007; 27(4C):2903-10. PubMed ID: 17695469
[TBL] [Abstract][Full Text] [Related]
51. [Mistletoe in the treatment of cancer patients].
Rostock M
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 May; 63(5):535-540. PubMed ID: 32211937
[TBL] [Abstract][Full Text] [Related]
52. Time and Dose-Dependent Effects of Viscum Album Quercus on Rabbit Spermatozoa Motility and Viability in Vitro.
Halo M; Massanyi P; Gren A; Lasak A; Slanina T; Ondruska L; Muchacka R; Galbavy D; Ivanic P; Schneir ER; Formicki G
Physiol Res; 2019 Dec; 68(6):955-972. PubMed ID: 31647301
[TBL] [Abstract][Full Text] [Related]
53. Reduction of leukopenia in mice by "viscum album" administration during radiation and chemotherapy.
Kuttan G; Kuttan R
Tumori; 1993 Feb; 79(1):74-6. PubMed ID: 8497925
[TBL] [Abstract][Full Text] [Related]
54. [Advanced adenoma in 3700 colonoscopies].
Barreda Costa C; Vila Gutierrez S; Salazar Cabrera F; Barriga Calle E; Velarde Criado H; Barriga Briceño J
Rev Gastroenterol Peru; 2010; 30(2):113-20. PubMed ID: 20644602
[TBL] [Abstract][Full Text] [Related]
55. Phytochemical profile and therapeutic potential of Viscum album L.
Nazaruk J; Orlikowski P
Nat Prod Res; 2016; 30(4):373-85. PubMed ID: 25813519
[TBL] [Abstract][Full Text] [Related]
56. Immunological response to mistletoe (Viscum album L.) in cancer patients: a four-case series.
Gardin NE
Phytother Res; 2009 Mar; 23(3):407-11. PubMed ID: 19003944
[TBL] [Abstract][Full Text] [Related]
57. Safety of Combined Treatment With Monoclonal Antibodies and Viscum album L Preparations.
Schad F; Axtner J; Kröz M; Matthes H; Steele ML
Integr Cancer Ther; 2018 Mar; 17(1):41-51. PubMed ID: 29444603
[TBL] [Abstract][Full Text] [Related]
58. Chemical pleurodesis using a Viscum album extract in infants with congenital chylothorax.
Cho HJ; Na KJ; Kim DW; Choi YE; Ma JS; Jeong IS
Eur J Pediatr; 2014 Jun; 173(6):823-6. PubMed ID: 24573572
[TBL] [Abstract][Full Text] [Related]
59. ViscumTT induces apoptosis and alters IAP expression in osteosarcoma in vitro and has synergistic action when combined with different chemotherapeutic drugs.
Kleinsimon S; Kauczor G; Jaeger S; Eggert A; Seifert G; Delebinski C
BMC Complement Altern Med; 2017 Jan; 17(1):26. PubMed ID: 28061770
[TBL] [Abstract][Full Text] [Related]
60. The Viscum album preparation Isorel inhibits the growth of melanoma B16F10 by influencing the tumour-host relationship.
Zarkovic N; Zarkovic K; Grainca S; Kissel D; Jurin M
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S17-22. PubMed ID: 9179362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
